Filter
3661
Filtered Results: 3661
Text search:
side
effects
Featured
Recommendations
378
New Publications
937
Language
Document type
No document type
2164
Studies & Reports
517
Guidelines
469
Manuals
188
Fact sheets
106
Training Material
87
Strategic & Response Plan
67
Situation Updates
18
Infographics
15
Brochures
11
Resource Platforms
11
Videos
7
App
1
Countries / Regions
India
289
Global
132
Kenya
109
South Africa
103
Ethiopia
75
Nepal
74
Uganda
64
Western and Central Europe
63
Sierra Leone
57
Tanzania
57
Rwanda
54
Malawi
50
Syria
47
Myanmar / Burma
44
Nigeria
43
Bangladesh
43
Africa
41
Latin America and the Carribbean
41
Zambia
41
Liberia
41
Ghana
39
Philippines
38
Namibia
33
Ukraine
27
Cambodia
26
Eastern Europe
25
South–East Asia Region
24
Senegal
23
Zimbabwe
22
West and Central Africa
21
Indonesia
21
Congo, Democratic Republic of
19
East and Southern Africa
19
South Sudan
19
Asia
18
Germany
18
Botswana
18
Lesotho
17
Middle East and North Africa
17
Mozambique
15
Brazil
14
Haiti
13
Guinea
12
Venezuela
11
Yemen
11
Eswatini/ Swaziland
11
Burkina Faso
10
Afghanistan
10
Eastern Europe and Central Asia
10
Russia
10
Thailand
8
USA
8
China
7
Cameroon
7
Lebanon
7
Sri Lanka
7
Iraq
7
Pakistan
7
Tajikistan
6
Turkey
6
Vietnam
6
Somalia
6
Colombia
5
Jordan
5
Jamaica
5
Sudan
5
Mexico
4
Iran
4
Albania
4
Burundi
4
North America
4
Argentina
4
Georgia
4
Central African Republic
4
North Macedonia
3
Timor Leste/ East Timor
3
Benin
3
Laos
3
Kyrgyzstan
3
Peru
3
Southern Africa
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Moldova
3
Mali
3
Bhutan
3
Chile
2
Malaysia
2
Morocco
2
Croatia
2
Lithuania
2
Western Pacific Region
2
Turkmenistan
2
Japan
2
Mauritius
2
United Kingdom
2
Portugal
2
Spain
2
Bolivia
2
Egypt
2
Palestine
2
Angola
2
Libya
2
Madagascar
2
North Korea
1
Serbia
1
Australia
1
Gambia
1
Togo
1
Kazakhstan
1
Fiji
1
Singapore
1
Estonia
1
Niger
1
Mongolia
1
Armenia
1
Hungary
1
Ireland
1
Saudi Arabia
1
Paraguay
1
Tunisia
1
Norway
1
South Korea
1
Azerbaijan
1
Belarus
1
French Guyana
1
Bosnia and Herzegovina
1
Nicaragua
1
Greece
1
Honduras
1
Chad
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1345
Clinical Guidelines
399
Women & Child Health
214
Public Health
192
Key Resources
120
Capacity Building
101
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
Mental Health
337
HIV
276
COVID-19
271
TB
221
Caregiver
100
Conflict
97
Planetary Health
94
NTDs
93
Disability
92
Pharmacy
91
AMR
89
NCDs
79
Refugee
78
Ebola
63
Rapid Response
52
Global Health Education
45
Natural Hazards
34
Specific Hazards
30
Health Financing Toolbox
27
Social Ethics
25
Cholera
14
Polio
14
Zika
13
Health Financing
1
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
This research report offers community perceptions of COVID-19 from migrants, refugees, host communities and indigenous populations in nine countries in the Americas: Argentina, Brazil, Bolivia, Colombia, Guatemala, Nicaragua, Jamaica, Panama and Trinidad and Tobago.
It reveals the myriad impacts ...
Europe and Central Asia Economic Update.
The Russian Federation’s war with Ukraine has triggered a catastrophic humanitarian crisis and threatened the stability of geopolitical relations. Economic output in the Europe and Central Asia region is forecast to contract by more than 4.1% in 2022—the...
This chapter addresses the biogeochemical cycles of carbon dioxide. (CO2), methane (CH4) and nitrous oxide (N2O)
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
The longlist of knowledge gaps is based on existing research agendas published in 2015 or later and expert input from reviewers of the first draft of the longlist. It only includes knowledge gaps focussing on a better
understanding of the relationship between global environmental change and human h...
This report presents a framework to link science, policy and practice for a comprehensive assessment of climate mitigation and adaptation investments and their impact on human health.The framework proposes to use weather and climate data to forecast health impacts over time, as well as biophysical a...
MOBILISIERUNG INLÄNDISCHER ÖFFENTLICHER RESSOURCEN FÜR GESUNDHEIT
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
